Global Pharmaceutical CMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Pharmaceutical CMO Services market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical CMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CMO Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CMO Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Pharmaceutical CMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CMO Services, with revenue, gross margin and global market share of Pharmaceutical CMO Services from 2018 to 2023.
Chapter 3, the Pharmaceutical CMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CMO Services.
Chapter 13, to describe Pharmaceutical CMO Services research findings and conclusion.
This report is a detailed and comprehensive analysis for global Pharmaceutical CMO Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CMO Services market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CMO Services market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CMO Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CMO Services market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Boehringer Ingelheim, FUJIFILM Diosynth Biotechnologies, AGC Chemicals and AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Active Pharmaceutical Ingredients (APIs)
- Finished Dose Formulations (FDFs)
- Packaging
- Pharmaceutical Industry
- Biotechnology Industry
- Lonza
- Boehringer Ingelheim
- FUJIFILM Diosynth Biotechnologies
- AGC Chemicals
- AbbVie
- Pfizer
- Evonik Health Care
- Delpharm
- Recipharm
- Teva API
- Catalent
- Esteve Quimica
- Fareva
- Patheon
- Piramal
- Hisun Pharmaceuticals
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Pharmaceutical CMO Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CMO Services, with revenue, gross margin and global market share of Pharmaceutical CMO Services from 2018 to 2023.
Chapter 3, the Pharmaceutical CMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CMO Services market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CMO Services.
Chapter 13, to describe Pharmaceutical CMO Services research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmaceutical CMO Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CMO Services by Type
1.3.1 Overview: Global Pharmaceutical CMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical CMO Services Consumption Value Market Share by Type in 2022
1.3.3 Active Pharmaceutical Ingredients (APIs)
1.3.4 Finished Dose Formulations (FDFs)
1.3.5 Packaging
1.4 Global Pharmaceutical CMO Services Market by Application
1.4.1 Overview: Global Pharmaceutical CMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Industry
1.4.3 Biotechnology Industry
1.5 Global Pharmaceutical CMO Services Market Size & Forecast
1.6 Global Pharmaceutical CMO Services Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CMO Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical CMO Services Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Pharmaceutical CMO Services Product and Solutions
2.1.4 Lonza Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Product and Solutions
2.2.4 Boehringer Ingelheim Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
2.3 FUJIFILM Diosynth Biotechnologies
2.3.1 FUJIFILM Diosynth Biotechnologies Details
2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
2.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product and Solutions
2.3.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.4 AGC Chemicals
2.4.1 AGC Chemicals Details
2.4.2 AGC Chemicals Major Business
2.4.3 AGC Chemicals Pharmaceutical CMO Services Product and Solutions
2.4.4 AGC Chemicals Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AGC Chemicals Recent Developments and Future Plans
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Pharmaceutical CMO Services Product and Solutions
2.5.4 AbbVie Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AbbVie Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Pharmaceutical CMO Services Product and Solutions
2.6.4 Pfizer Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Evonik Health Care
2.7.1 Evonik Health Care Details
2.7.2 Evonik Health Care Major Business
2.7.3 Evonik Health Care Pharmaceutical CMO Services Product and Solutions
2.7.4 Evonik Health Care Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Evonik Health Care Recent Developments and Future Plans
2.8 Delpharm
2.8.1 Delpharm Details
2.8.2 Delpharm Major Business
2.8.3 Delpharm Pharmaceutical CMO Services Product and Solutions
2.8.4 Delpharm Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Delpharm Recent Developments and Future Plans
2.9 Recipharm
2.9.1 Recipharm Details
2.9.2 Recipharm Major Business
2.9.3 Recipharm Pharmaceutical CMO Services Product and Solutions
2.9.4 Recipharm Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Recipharm Recent Developments and Future Plans
2.10 Teva API
2.10.1 Teva API Details
2.10.2 Teva API Major Business
2.10.3 Teva API Pharmaceutical CMO Services Product and Solutions
2.10.4 Teva API Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Teva API Recent Developments and Future Plans
2.11 Catalent
2.11.1 Catalent Details
2.11.2 Catalent Major Business
2.11.3 Catalent Pharmaceutical CMO Services Product and Solutions
2.11.4 Catalent Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Catalent Recent Developments and Future Plans
2.12 Esteve Quimica
2.12.1 Esteve Quimica Details
2.12.2 Esteve Quimica Major Business
2.12.3 Esteve Quimica Pharmaceutical CMO Services Product and Solutions
2.12.4 Esteve Quimica Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Esteve Quimica Recent Developments and Future Plans
2.13 Fareva
2.13.1 Fareva Details
2.13.2 Fareva Major Business
2.13.3 Fareva Pharmaceutical CMO Services Product and Solutions
2.13.4 Fareva Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fareva Recent Developments and Future Plans
2.14 Patheon
2.14.1 Patheon Details
2.14.2 Patheon Major Business
2.14.3 Patheon Pharmaceutical CMO Services Product and Solutions
2.14.4 Patheon Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Patheon Recent Developments and Future Plans
2.15 Piramal
2.15.1 Piramal Details
2.15.2 Piramal Major Business
2.15.3 Piramal Pharmaceutical CMO Services Product and Solutions
2.15.4 Piramal Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Piramal Recent Developments and Future Plans
2.16 Hisun Pharmaceuticals
2.16.1 Hisun Pharmaceuticals Details
2.16.2 Hisun Pharmaceuticals Major Business
2.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Product and Solutions
2.16.4 Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Hisun Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceutical CMO Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical CMO Services by Company Revenue
3.2.2 Top 3 Pharmaceutical CMO Services Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical CMO Services Players Market Share in 2022
3.3 Pharmaceutical CMO Services Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CMO Services Market: Region Footprint
3.3.2 Pharmaceutical CMO Services Market: Company Product Type Footprint
3.3.3 Pharmaceutical CMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceutical CMO Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical CMO Services Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical CMO Services Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical CMO Services Market Size by Country
6.3.1 North America Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical CMO Services Market Size by Country
7.3.1 Europe Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical CMO Services Market Size by Country
9.3.1 South America Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Pharmaceutical CMO Services Market Drivers
11.2 Pharmaceutical CMO Services Market Restraints
11.3 Pharmaceutical CMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmaceutical CMO Services Industry Chain
12.2 Pharmaceutical CMO Services Upstream Analysis
12.3 Pharmaceutical CMO Services Midstream Analysis
12.4 Pharmaceutical CMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Pharmaceutical CMO Services
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CMO Services by Type
1.3.1 Overview: Global Pharmaceutical CMO Services Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical CMO Services Consumption Value Market Share by Type in 2022
1.3.3 Active Pharmaceutical Ingredients (APIs)
1.3.4 Finished Dose Formulations (FDFs)
1.3.5 Packaging
1.4 Global Pharmaceutical CMO Services Market by Application
1.4.1 Overview: Global Pharmaceutical CMO Services Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Industry
1.4.3 Biotechnology Industry
1.5 Global Pharmaceutical CMO Services Market Size & Forecast
1.6 Global Pharmaceutical CMO Services Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CMO Services Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical CMO Services Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical CMO Services Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Pharmaceutical CMO Services Product and Solutions
2.1.4 Lonza Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Boehringer Ingelheim
2.2.1 Boehringer Ingelheim Details
2.2.2 Boehringer Ingelheim Major Business
2.2.3 Boehringer Ingelheim Pharmaceutical CMO Services Product and Solutions
2.2.4 Boehringer Ingelheim Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer Ingelheim Recent Developments and Future Plans
2.3 FUJIFILM Diosynth Biotechnologies
2.3.1 FUJIFILM Diosynth Biotechnologies Details
2.3.2 FUJIFILM Diosynth Biotechnologies Major Business
2.3.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product and Solutions
2.3.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.4 AGC Chemicals
2.4.1 AGC Chemicals Details
2.4.2 AGC Chemicals Major Business
2.4.3 AGC Chemicals Pharmaceutical CMO Services Product and Solutions
2.4.4 AGC Chemicals Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AGC Chemicals Recent Developments and Future Plans
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business
2.5.3 AbbVie Pharmaceutical CMO Services Product and Solutions
2.5.4 AbbVie Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AbbVie Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Pharmaceutical CMO Services Product and Solutions
2.6.4 Pfizer Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Evonik Health Care
2.7.1 Evonik Health Care Details
2.7.2 Evonik Health Care Major Business
2.7.3 Evonik Health Care Pharmaceutical CMO Services Product and Solutions
2.7.4 Evonik Health Care Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Evonik Health Care Recent Developments and Future Plans
2.8 Delpharm
2.8.1 Delpharm Details
2.8.2 Delpharm Major Business
2.8.3 Delpharm Pharmaceutical CMO Services Product and Solutions
2.8.4 Delpharm Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Delpharm Recent Developments and Future Plans
2.9 Recipharm
2.9.1 Recipharm Details
2.9.2 Recipharm Major Business
2.9.3 Recipharm Pharmaceutical CMO Services Product and Solutions
2.9.4 Recipharm Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Recipharm Recent Developments and Future Plans
2.10 Teva API
2.10.1 Teva API Details
2.10.2 Teva API Major Business
2.10.3 Teva API Pharmaceutical CMO Services Product and Solutions
2.10.4 Teva API Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Teva API Recent Developments and Future Plans
2.11 Catalent
2.11.1 Catalent Details
2.11.2 Catalent Major Business
2.11.3 Catalent Pharmaceutical CMO Services Product and Solutions
2.11.4 Catalent Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Catalent Recent Developments and Future Plans
2.12 Esteve Quimica
2.12.1 Esteve Quimica Details
2.12.2 Esteve Quimica Major Business
2.12.3 Esteve Quimica Pharmaceutical CMO Services Product and Solutions
2.12.4 Esteve Quimica Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Esteve Quimica Recent Developments and Future Plans
2.13 Fareva
2.13.1 Fareva Details
2.13.2 Fareva Major Business
2.13.3 Fareva Pharmaceutical CMO Services Product and Solutions
2.13.4 Fareva Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Fareva Recent Developments and Future Plans
2.14 Patheon
2.14.1 Patheon Details
2.14.2 Patheon Major Business
2.14.3 Patheon Pharmaceutical CMO Services Product and Solutions
2.14.4 Patheon Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Patheon Recent Developments and Future Plans
2.15 Piramal
2.15.1 Piramal Details
2.15.2 Piramal Major Business
2.15.3 Piramal Pharmaceutical CMO Services Product and Solutions
2.15.4 Piramal Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Piramal Recent Developments and Future Plans
2.16 Hisun Pharmaceuticals
2.16.1 Hisun Pharmaceuticals Details
2.16.2 Hisun Pharmaceuticals Major Business
2.16.3 Hisun Pharmaceuticals Pharmaceutical CMO Services Product and Solutions
2.16.4 Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Hisun Pharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceutical CMO Services Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical CMO Services by Company Revenue
3.2.2 Top 3 Pharmaceutical CMO Services Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical CMO Services Players Market Share in 2022
3.3 Pharmaceutical CMO Services Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CMO Services Market: Region Footprint
3.3.2 Pharmaceutical CMO Services Market: Company Product Type Footprint
3.3.3 Pharmaceutical CMO Services Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceutical CMO Services Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical CMO Services Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical CMO Services Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical CMO Services Market Size by Country
6.3.1 North America Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical CMO Services Market Size by Country
7.3.1 Europe Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical CMO Services Market Size by Country
9.3.1 South America Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical CMO Services Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Pharmaceutical CMO Services Market Drivers
11.2 Pharmaceutical CMO Services Market Restraints
11.3 Pharmaceutical CMO Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmaceutical CMO Services Industry Chain
12.2 Pharmaceutical CMO Services Upstream Analysis
12.3 Pharmaceutical CMO Services Midstream Analysis
12.4 Pharmaceutical CMO Services Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Pharmaceutical CMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical CMO Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical CMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical CMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Pharmaceutical CMO Services Product and Solutions
Table 8. Lonza Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Pharmaceutical CMO Services Product and Solutions
Table 13. Boehringer Ingelheim Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Boehringer Ingelheim Recent Developments and Future Plans
Table 15. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 16. FUJIFILM Diosynth Biotechnologies Major Business
Table 17. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product and Solutions
Table 18. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 20. AGC Chemicals Company Information, Head Office, and Major Competitors
Table 21. AGC Chemicals Major Business
Table 22. AGC Chemicals Pharmaceutical CMO Services Product and Solutions
Table 23. AGC Chemicals Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AGC Chemicals Recent Developments and Future Plans
Table 25. AbbVie Company Information, Head Office, and Major Competitors
Table 26. AbbVie Major Business
Table 27. AbbVie Pharmaceutical CMO Services Product and Solutions
Table 28. AbbVie Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AbbVie Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Pharmaceutical CMO Services Product and Solutions
Table 33. Pfizer Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Evonik Health Care Company Information, Head Office, and Major Competitors
Table 36. Evonik Health Care Major Business
Table 37. Evonik Health Care Pharmaceutical CMO Services Product and Solutions
Table 38. Evonik Health Care Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Evonik Health Care Recent Developments and Future Plans
Table 40. Delpharm Company Information, Head Office, and Major Competitors
Table 41. Delpharm Major Business
Table 42. Delpharm Pharmaceutical CMO Services Product and Solutions
Table 43. Delpharm Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Delpharm Recent Developments and Future Plans
Table 45. Recipharm Company Information, Head Office, and Major Competitors
Table 46. Recipharm Major Business
Table 47. Recipharm Pharmaceutical CMO Services Product and Solutions
Table 48. Recipharm Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Recipharm Recent Developments and Future Plans
Table 50. Teva API Company Information, Head Office, and Major Competitors
Table 51. Teva API Major Business
Table 52. Teva API Pharmaceutical CMO Services Product and Solutions
Table 53. Teva API Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Teva API Recent Developments and Future Plans
Table 55. Catalent Company Information, Head Office, and Major Competitors
Table 56. Catalent Major Business
Table 57. Catalent Pharmaceutical CMO Services Product and Solutions
Table 58. Catalent Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Catalent Recent Developments and Future Plans
Table 60. Esteve Quimica Company Information, Head Office, and Major Competitors
Table 61. Esteve Quimica Major Business
Table 62. Esteve Quimica Pharmaceutical CMO Services Product and Solutions
Table 63. Esteve Quimica Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Esteve Quimica Recent Developments and Future Plans
Table 65. Fareva Company Information, Head Office, and Major Competitors
Table 66. Fareva Major Business
Table 67. Fareva Pharmaceutical CMO Services Product and Solutions
Table 68. Fareva Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Fareva Recent Developments and Future Plans
Table 70. Patheon Company Information, Head Office, and Major Competitors
Table 71. Patheon Major Business
Table 72. Patheon Pharmaceutical CMO Services Product and Solutions
Table 73. Patheon Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Patheon Recent Developments and Future Plans
Table 75. Piramal Company Information, Head Office, and Major Competitors
Table 76. Piramal Major Business
Table 77. Piramal Pharmaceutical CMO Services Product and Solutions
Table 78. Piramal Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Piramal Recent Developments and Future Plans
Table 80. Hisun Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 81. Hisun Pharmaceuticals Major Business
Table 82. Hisun Pharmaceuticals Pharmaceutical CMO Services Product and Solutions
Table 83. Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Hisun Pharmaceuticals Recent Developments and Future Plans
Table 85. Global Pharmaceutical CMO Services Revenue (USD Million) by Players (2018-2023)
Table 86. Global Pharmaceutical CMO Services Revenue Share by Players (2018-2023)
Table 87. Breakdown of Pharmaceutical CMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Pharmaceutical CMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Pharmaceutical CMO Services Players
Table 90. Pharmaceutical CMO Services Market: Company Product Type Footprint
Table 91. Pharmaceutical CMO Services Market: Company Product Application Footprint
Table 92. Pharmaceutical CMO Services New Market Entrants and Barriers to Market Entry
Table 93. Pharmaceutical CMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Pharmaceutical CMO Services Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Pharmaceutical CMO Services Consumption Value Share by Type (2018-2023)
Table 96. Global Pharmaceutical CMO Services Consumption Value Forecast by Type (2024-2029)
Table 97. Global Pharmaceutical CMO Services Consumption Value by Application (2018-2023)
Table 98. Global Pharmaceutical CMO Services Consumption Value Forecast by Application (2024-2029)
Table 99. North America Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Pharmaceutical CMO Services Raw Material
Table 130. Key Suppliers of Pharmaceutical CMO Services Raw Materials
Table 1. Global Pharmaceutical CMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical CMO Services Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical CMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical CMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Pharmaceutical CMO Services Product and Solutions
Table 8. Lonza Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 11. Boehringer Ingelheim Major Business
Table 12. Boehringer Ingelheim Pharmaceutical CMO Services Product and Solutions
Table 13. Boehringer Ingelheim Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Boehringer Ingelheim Recent Developments and Future Plans
Table 15. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 16. FUJIFILM Diosynth Biotechnologies Major Business
Table 17. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Product and Solutions
Table 18. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 20. AGC Chemicals Company Information, Head Office, and Major Competitors
Table 21. AGC Chemicals Major Business
Table 22. AGC Chemicals Pharmaceutical CMO Services Product and Solutions
Table 23. AGC Chemicals Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AGC Chemicals Recent Developments and Future Plans
Table 25. AbbVie Company Information, Head Office, and Major Competitors
Table 26. AbbVie Major Business
Table 27. AbbVie Pharmaceutical CMO Services Product and Solutions
Table 28. AbbVie Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AbbVie Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Pharmaceutical CMO Services Product and Solutions
Table 33. Pfizer Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Evonik Health Care Company Information, Head Office, and Major Competitors
Table 36. Evonik Health Care Major Business
Table 37. Evonik Health Care Pharmaceutical CMO Services Product and Solutions
Table 38. Evonik Health Care Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Evonik Health Care Recent Developments and Future Plans
Table 40. Delpharm Company Information, Head Office, and Major Competitors
Table 41. Delpharm Major Business
Table 42. Delpharm Pharmaceutical CMO Services Product and Solutions
Table 43. Delpharm Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Delpharm Recent Developments and Future Plans
Table 45. Recipharm Company Information, Head Office, and Major Competitors
Table 46. Recipharm Major Business
Table 47. Recipharm Pharmaceutical CMO Services Product and Solutions
Table 48. Recipharm Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Recipharm Recent Developments and Future Plans
Table 50. Teva API Company Information, Head Office, and Major Competitors
Table 51. Teva API Major Business
Table 52. Teva API Pharmaceutical CMO Services Product and Solutions
Table 53. Teva API Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Teva API Recent Developments and Future Plans
Table 55. Catalent Company Information, Head Office, and Major Competitors
Table 56. Catalent Major Business
Table 57. Catalent Pharmaceutical CMO Services Product and Solutions
Table 58. Catalent Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Catalent Recent Developments and Future Plans
Table 60. Esteve Quimica Company Information, Head Office, and Major Competitors
Table 61. Esteve Quimica Major Business
Table 62. Esteve Quimica Pharmaceutical CMO Services Product and Solutions
Table 63. Esteve Quimica Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Esteve Quimica Recent Developments and Future Plans
Table 65. Fareva Company Information, Head Office, and Major Competitors
Table 66. Fareva Major Business
Table 67. Fareva Pharmaceutical CMO Services Product and Solutions
Table 68. Fareva Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Fareva Recent Developments and Future Plans
Table 70. Patheon Company Information, Head Office, and Major Competitors
Table 71. Patheon Major Business
Table 72. Patheon Pharmaceutical CMO Services Product and Solutions
Table 73. Patheon Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Patheon Recent Developments and Future Plans
Table 75. Piramal Company Information, Head Office, and Major Competitors
Table 76. Piramal Major Business
Table 77. Piramal Pharmaceutical CMO Services Product and Solutions
Table 78. Piramal Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Piramal Recent Developments and Future Plans
Table 80. Hisun Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 81. Hisun Pharmaceuticals Major Business
Table 82. Hisun Pharmaceuticals Pharmaceutical CMO Services Product and Solutions
Table 83. Hisun Pharmaceuticals Pharmaceutical CMO Services Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Hisun Pharmaceuticals Recent Developments and Future Plans
Table 85. Global Pharmaceutical CMO Services Revenue (USD Million) by Players (2018-2023)
Table 86. Global Pharmaceutical CMO Services Revenue Share by Players (2018-2023)
Table 87. Breakdown of Pharmaceutical CMO Services by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Pharmaceutical CMO Services, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Pharmaceutical CMO Services Players
Table 90. Pharmaceutical CMO Services Market: Company Product Type Footprint
Table 91. Pharmaceutical CMO Services Market: Company Product Application Footprint
Table 92. Pharmaceutical CMO Services New Market Entrants and Barriers to Market Entry
Table 93. Pharmaceutical CMO Services Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Pharmaceutical CMO Services Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Pharmaceutical CMO Services Consumption Value Share by Type (2018-2023)
Table 96. Global Pharmaceutical CMO Services Consumption Value Forecast by Type (2024-2029)
Table 97. Global Pharmaceutical CMO Services Consumption Value by Application (2018-2023)
Table 98. Global Pharmaceutical CMO Services Consumption Value Forecast by Application (2024-2029)
Table 99. North America Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Pharmaceutical CMO Services Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Pharmaceutical CMO Services Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Pharmaceutical CMO Services Raw Material
Table 130. Key Suppliers of Pharmaceutical CMO Services Raw Materials
LIST OF FIGURES
Figure 1. Pharmaceutical CMO Services Picture
Figure 2. Global Pharmaceutical CMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical CMO Services Consumption Value Market Share by Type in 2022
Figure 4. Active Pharmaceutical Ingredients (APIs)
Figure 5. Finished Dose Formulations (FDFs)
Figure 6. Packaging
Figure 7. Global Pharmaceutical CMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Pharmaceutical CMO Services Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Industry Picture
Figure 10. Biotechnology Industry Picture
Figure 11. Global Pharmaceutical CMO Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pharmaceutical CMO Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Pharmaceutical CMO Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Pharmaceutical CMO Services Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Pharmaceutical CMO Services Consumption Value Market Share by Region in 2022
Figure 16. North America Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Pharmaceutical CMO Services Revenue Share by Players in 2022
Figure 22. Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Pharmaceutical CMO Services Market Share in 2022
Figure 24. Global Top 6 Players Pharmaceutical CMO Services Market Share in 2022
Figure 25. Global Pharmaceutical CMO Services Consumption Value Share by Type (2018-2023)
Figure 26. Global Pharmaceutical CMO Services Market Share Forecast by Type (2024-2029)
Figure 27. Global Pharmaceutical CMO Services Consumption Value Share by Application (2018-2023)
Figure 28. Global Pharmaceutical CMO Services Market Share Forecast by Application (2024-2029)
Figure 29. North America Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 39. France Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Pharmaceutical CMO Services Consumption Value Market Share by Region (2018-2029)
Figure 46. China Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 49. India Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 63. Pharmaceutical CMO Services Market Drivers
Figure 64. Pharmaceutical CMO Services Market Restraints
Figure 65. Pharmaceutical CMO Services Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Pharmaceutical CMO Services in 2022
Figure 68. Manufacturing Process Analysis of Pharmaceutical CMO Services
Figure 69. Pharmaceutical CMO Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Pharmaceutical CMO Services Picture
Figure 2. Global Pharmaceutical CMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical CMO Services Consumption Value Market Share by Type in 2022
Figure 4. Active Pharmaceutical Ingredients (APIs)
Figure 5. Finished Dose Formulations (FDFs)
Figure 6. Packaging
Figure 7. Global Pharmaceutical CMO Services Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Pharmaceutical CMO Services Consumption Value Market Share by Application in 2022
Figure 9. Pharmaceutical Industry Picture
Figure 10. Biotechnology Industry Picture
Figure 11. Global Pharmaceutical CMO Services Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pharmaceutical CMO Services Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Pharmaceutical CMO Services Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Pharmaceutical CMO Services Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Pharmaceutical CMO Services Consumption Value Market Share by Region in 2022
Figure 16. North America Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Pharmaceutical CMO Services Revenue Share by Players in 2022
Figure 22. Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Pharmaceutical CMO Services Market Share in 2022
Figure 24. Global Top 6 Players Pharmaceutical CMO Services Market Share in 2022
Figure 25. Global Pharmaceutical CMO Services Consumption Value Share by Type (2018-2023)
Figure 26. Global Pharmaceutical CMO Services Market Share Forecast by Type (2024-2029)
Figure 27. Global Pharmaceutical CMO Services Consumption Value Share by Application (2018-2023)
Figure 28. Global Pharmaceutical CMO Services Market Share Forecast by Application (2024-2029)
Figure 29. North America Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 39. France Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Pharmaceutical CMO Services Consumption Value Market Share by Region (2018-2029)
Figure 46. China Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 49. India Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Pharmaceutical CMO Services Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Pharmaceutical CMO Services Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Pharmaceutical CMO Services Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Pharmaceutical CMO Services Consumption Value (2018-2029) & (USD Million)
Figure 63. Pharmaceutical CMO Services Market Drivers
Figure 64. Pharmaceutical CMO Services Market Restraints
Figure 65. Pharmaceutical CMO Services Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Pharmaceutical CMO Services in 2022
Figure 68. Manufacturing Process Analysis of Pharmaceutical CMO Services
Figure 69. Pharmaceutical CMO Services Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
